2nd Circ. Revives Actos Antitrust Suit But Limits Scope
The Second Circuit on Wednesday revived a proposed class action by purchasers of diabetes drug Actos accusing Takeda of delaying generic competition for the drug, saying they could pursue allegations that...To view the full article, register now.
Already a subscriber? Click here to view full article